Kimberly-Clark (NYSE:KMB) is scheduled to announce Q4 earnings results on Wednesday, January 25th, before market open.

The consensus EPS Estimate is $1.51 (+16.2% Y/Y) and the consensus Revenue Estimate is $4.99B (+0.4% Y/Y).

Over the last 2 years, KMB has beaten EPS estimates 50% of the time and has beaten revenue estimates 75% of the time.

Over the last 3 months, EPS estimates have seen 12 upward revisions and 2 downward. Revenue estimates have seen 7 upward revisions and 3 downward.

JPMorgan and UBS raised the price target on the stock ahead of Q4 earnings.

• UBS analyst Peter Grom raised the price target to $136 from $129 and maintains a Neutral rating on the shares given the wide range of potential outcomes for 2023 guidance and valuation that remains expensive vs. historical averages, Grom tells investors in a research note. While the analyst sees room for gross margin recovery on the horizon, it is unclear how much of the profitability improvement will flow to the bottom line.
• JPMorgan analyst Andrea Teixeira raised the price target to $124 from $120 and maintains an Underweight rating on the shares. The analyst expects price inflation to continue to drive sales momentum for the majority of the 14 household and personal care companies she covers in Q4. However, she anticipates “weak” earnings performance for most in the sector. The Q4 reports will not matter much, and guidance and commentary will be crucial to drive stocks in the short term, Teixeira tells investors in a research note.